CyberKnife radiosurgery for stage I lung cancer: results at 36 months

Image-guided robotic stereotactic radiosurgery of lung tumors with CyberKnife(R) achieves excellent rates of local disease control with limited toxicity to surrounding tissues and, in many cases, might be curative for patients for whom surgery is not an option.

Clinical accuracy of the respiratory tumor tracking system of the CyberKnife

Analyses of the log files of real clinical cases have shown that the geometric error caused by respiratory motion is substantially reduced by the application of respiratory motion tracking.

A motion phantom study on helical TomoTherapy: the dosimetric impacts of delivery technique and motion

Helical tomotherapy (HT) can potentially be used for lung cancer treatment including stereotactic radiosurgery because of its advanced image guidance and its ability to deliver highly conformal dose distributions.

TomoTherapy® CTrue™ Adaptive Lung Case

Using CTrue technology, the shifting tumor can be correctly aligned before every fraction and dose can be overlaid to check target coverage and organ sparing.

SBRT for Non-Small Cell Carcinoma

Using the TomoTherapy® Hi·Art® system’s precise dose guidance capabilities, the oncologist delivered intense radiation directly to the tumor during a week and a half of treatment. The patient experienced no side effects during this time and continued to work as a nurse. Three years later, she remains disease free.

Non-Invasive Stereotactic Radiosurgical Treatment of Non-Small Cell Lung Cancer

This patient had an excellent initial outcome with the CyberKnife System using Xsight® Lung Tracking; the patient was able to undergo treatment completely non-invasively without implanted fiducials or markers.

Synchronous Bilateral Stage 1A Non-Small Cell Carcinoma

Patient was unwilling to undergo a second thoracotomy, and instead chose to receive CyberKnife® treatment of the lesion with concurrent chemotherapy.

Non-Small Cell Lung Cancer - Left Upper Lung

Three months after treatment, the patient reported no evidence of local regional recurrence or treatment-related toxicity.

Treating inoperable early stage lung cancer with the CyberKnife System

The purpose of this study is to assess the short and long-term outcomes after CyberKnife stereotactic radiosurgery for early stage non-small cell lung cancer (NSCLC) in patients who are medically inoperable.